Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Stem Cell Culture01:17

Stem Cell Culture

5.2K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
5.2K
Embryonic Stem Cells00:57

Embryonic Stem Cells

3.6K
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
3.6K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.1K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

4.2K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.2K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Claudio Bordignon.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

The inflammatory "death-to-life" loop in VEXAS syndrome.

Blood·2026
Same author

Selection of human hematopoietic stem cells bearing the intended functional edit by transient AND-gate reporters.

Nature biotechnology·2026
Same author

Tumor-targeted interferon-α gene therapy for glioblastoma: a phase 1 trial.

Nature medicine·2026
Same author

VEXAS syndrome.

Nature reviews. Disease primers·2026
Same author

Editorial: Safety and efficacy of CRISPR/Cas-based genome editing tools: applications and considerations in cell and gene therapy.

Frontiers in immunology·2026

Video Experimental Relacionado

Updated: Jul 21, 2025

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells
05:32

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

Published on: February 16, 2024

482

Un paso hacia la ingeniería de células madre in vivo

Samuele Ferrari1, Luigi Naldini1,2

  • 1San Raffaele Telethon Institute for Gene Therapy, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele, Milan, Italy.

Science (New York, N.Y.)
|July 27, 2023
PubMed
Resumen

La entrega de ARN mensajero (ARNm) tiene el potencial de revolucionar la terapia génica de células madre hematopoyéticas. Este enfoque innovador puede alterar significativamente los paradigmas actuales de tratamiento para los trastornos genéticos que afectan a las células madre sanguíneas.

Más Videos Relacionados

Generation and Grafting of Tissue-engineered Vessels in a Mouse Model
13:04

Generation and Grafting of Tissue-engineered Vessels in a Mouse Model

Published on: March 18, 2015

12.1K
Tissue Engineering by Intrinsic Vascularization in an In Vivo Tissue Engineering Chamber
09:55

Tissue Engineering by Intrinsic Vascularization in an In Vivo Tissue Engineering Chamber

Published on: May 30, 2016

8.9K

Videos de Experimentos Relacionados

Last Updated: Jul 21, 2025

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells
05:32

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

Published on: February 16, 2024

482
Generation and Grafting of Tissue-engineered Vessels in a Mouse Model
13:04

Generation and Grafting of Tissue-engineered Vessels in a Mouse Model

Published on: March 18, 2015

12.1K
Tissue Engineering by Intrinsic Vascularization in an In Vivo Tissue Engineering Chamber
09:55

Tissue Engineering by Intrinsic Vascularization in an In Vivo Tissue Engineering Chamber

Published on: May 30, 2016

8.9K

Área de la Ciencia:

  • * Hematología y terapia génica
  • * Biología molecular y administración de fármacos

Sus antecedentes:

  • * La terapia génica con células madre hematopoyéticas (HSC, por sus siglas en inglés) es un tratamiento prometedor para los trastornos genéticos de la sangre.
  • * Los métodos actuales de terapia génica se enfrentan a desafíos en cuanto a eficiencia y seguridad.

Objetivo del estudio:

  • * Explorar el potencial del ARN mensajero (ARNm) para la transmisión de genes en las células HSC.
  • * Evaluar el ARNm como un enfoque transformador en la terapia génica HSC.

Principales métodos:

  • * Investigación de sistemas de suministro basados en ARNm para HSC.
  • * Evaluación de la eficacia y viabilidad de este nuevo método de transferencia de genes.

Principales resultados:

  • * La administración de ARNm demuestra potencial para modificar la terapia génica HSC.
  • * Este enfoque puede superar las limitaciones de las técnicas de terapia génica existentes.

Conclusiones:

  • * La entrega basada en ARNm representa un cambio de paradigma para la terapia génica HSC.
  • * Se requiere más investigación para realizar plenamente el potencial terapéutico del ARNm en este campo.